Volume 79, Issue 12, Pages (June 2011)

Slides:



Advertisements
Similar presentations
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
Advertisements

Volume 82, Issue 12, Pages (December 2012)
Urine Potassium Excretion, Kidney Failure, and Mortality in CKD
Improved prognosis of diabetic nephropathy in type 1 diabetes
Chronic Kidney Disease in Diabetes
Chapter 1: CKD in the General Population
Volume 80, Issue 1, Pages (July 2011)
Copyright © 2012 American Medical Association. All rights reserved.
Arterioscler Thromb Vasc Biol
The percentage of subjects with de novo development of renal function impairment (GFR
Volume 80, Issue 1, Pages (July 2011)
Chapter 1: Definition and classification of CKD
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.
Volume 58, Issue 1, Pages (July 2000)
Chapter 1: CKD in the General Population
Volume 92, Issue 1, Pages (July 2017)
Volume 79, Issue 12, Pages (June 2011)
Gudrun Hatlen, Solfrid Romundstad, Stein I. Hallan 
Volume 80, Issue 9, (November 2011)
Chronic Kidney Disease in Diabetes
Volume 80, Issue 1, Pages (July 2011)
GFR Estimation: From Physiology to Public Health
Volume 88, Issue 2, Pages (August 2015)
Susumu Takahashi, Kazuyoshi Okada, Mitsuru Yanai  Kidney International 
Volume 66, Issue 1, Pages (July 2004)
Volume 82, Issue 12, Pages (December 2012)
Volume 86, Issue 4, Pages (October 2014)
Your Kidneys May Outlive You
GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration 
Midlife Blood Pressure and Late-Life GFR and Albuminuria: An Elderly General Population Cohort  Lesley A. Inker, MD, MS, Aghogho Okparavero, MD, Hocine.
Volume 75, Issue 10, Pages (May 2009)
Baseline Kidney Function as Predictor of Mortality and Kidney Disease Progression in HIV-Positive Patients  Fowzia Ibrahim, MSc, Lisa Hamzah, MRCP, Rachael.
Volume 93, Issue 1, Pages (January 2018)
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Yan Xie, Benjamin Bowe, Tingting Li, Hong Xian, Yan Yan, Ziyad Al-Aly 
Dietary phosphorus is associated with greater left ventricular mass
Volume 91, Issue 1, Pages (January 2017)
Volume 77, Issue 7, Pages (April 2010)
Bariatric surgery is associated with improvement in kidney outcomes
Jennifer E. Flythe, Stephen E. Kimmel, Steven M. Brunelli 
U-shaped effect of eGFR and mortality
Volume 76, Issue 6, Pages (September 2009)
Volume 83, Issue 4, Pages (April 2013)
Volume 86, Issue 3, Pages (September 2014)
Matthew K. Abramowitz, Thomas H. Hostetter, Michal L. Melamed 
Volume 58, Issue 1, Pages (July 2000)
Volume 81, Issue 6, Pages (March 2012)
Methods for guideline development
The kidney, a cardiovascular risk marker, and a new target for therapy
Improved prognosis of diabetic nephropathy in type 1 diabetes
Volume 85, Issue 5, Pages (May 2014)
Volume 73, Issue 8, Pages (April 2008)
Volume 84, Issue 4, Pages (October 2013)
Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD 
Volume 58, Issue 1, Pages (July 2000)
Volume 80, Issue 12, Pages (December 2011)
Volume 79, Issue 4, Pages (February 2011)
Volume 60, Issue 1, Pages (July 2001)
Volume 76, Issue 6, Pages (September 2009)
Blood lead and chronic kidney disease in the general United States population: Results from NHANES III  Paul Muntner, Jiang He, Suma Vupputuri, Josef.
Volume 60, Issue 3, Pages (September 2001)
Volume 75, Issue 1, Pages (January 2009)
Shoshana H. Ballew, PhD, Yan Chen, BS, Natalie R. Daya, MPH, Job G
Volume 61, Issue 2, Pages (February 2002)
Volume 81, Issue 11, Pages (June 2012)
Friends, social networks, and progressive chronic kidney disease
Volume 73, Issue 11, Pages (June 2008)
Association Between Hypertension and Kidney Function Decline: The Atherosclerosis Risk in Communities (ARIC) Study  Zhi Yu, Casey M. Rebholz, Eugenia.
Jacob J.E. Koopman, MD, PhD  American Journal of Kidney Diseases 
Presentation transcript:

Volume 79, Issue 12, Pages 1341-1352 (June 2011) Lower estimated glomerular filtration rate and higher albuminuria are associated with all- cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts  Marije van der Velde, Kunihiro Matsushita, Josef Coresh, Brad C. Astor, Mark Woodward, Andrew S. Levey, Paul E. de Jong, Ron T. Gansevoort  Kidney International  Volume 79, Issue 12, Pages 1341-1352 (June 2011) DOI: 10.1038/ki.2010.536 Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 1 Pooled adjusted hazard ratios (95% confidence interval) for all-cause (upper panels) and cardiovascular (lower panels) mortality in high-risk cohorts with albumin-to-creatinine ratio data, according to spline eGFR (left panels) and albumin-to-creatinine ratio (right panels), adjusted for each other and for age, sex, race, cardiovascular disease history, systolic blood pressure, diabetes, smoking, and total cholesterol (continuous analyses). Reference categories are eGFR 95ml/min per 1.73m2 and albumin-to-creatinine ratio 5mg/g, respectively. Dots represent statistical significance, triangles represent non-significance, and shaded areas are 95% confidence interval. ACR, albumin-to-creatinine ratio; eGFR, estimated glomerular filtration rate; HR, hazard ratio. Kidney International 2011 79, 1341-1352DOI: (10.1038/ki.2010.536) Copyright © 2011 International Society of Nephrology Terms and Conditions

Figure 2 Pooled adjusted hazard ratios (95% confidence interval) for all-cause (left panels) and cardiovascular (right panels) mortality according to eGFR and albuminuria based on continuous models with eGFR (splines), albuminuria (log-linear albumin-to-creatinine ratio or categorical dipstick), and their interaction terms. Upper panels show data for high-risk cohorts with albumin-to-creatinine ratio data, and lower panels for high-risk cohorts with dipstick data. Hazard ratios are adjusted for age, sex, race, cardiovascular disease history, systolic blood pressure, diabetes, smoking, and total cholesterol. Dots represent statistical significance, triangles represent non-significance, and shaded areas are 95% confidence interval. In this figure, albuminuria is treated categorically. Black lines and blue shading represent an albumin-to-creatinine ratio <30mg/g or dipstick negative or trace; green lines and green shading an albumin-to-creatinine ratio 30–299mg/g or dipstick 1+; and red lines and red shading an albumin-to-creatinine ratio ≥300mg/g or dipstick ≥2+. ACR, albumin-to-creatinine ratio; eGFR, estimated glomerular filtration rate; HR, hazard ratio. Kidney International 2011 79, 1341-1352DOI: (10.1038/ki.2010.536) Copyright © 2011 International Society of Nephrology Terms and Conditions

Kidney International 2011 79, 1341-1352DOI: (10.1038/ki.2010.536) Copyright © 2011 International Society of Nephrology Terms and Conditions

Kidney International 2011 79, 1341-1352DOI: (10.1038/ki.2010.536) Copyright © 2011 International Society of Nephrology Terms and Conditions

Kidney International 2011 79, 1341-1352DOI: (10.1038/ki.2010.536) Copyright © 2011 International Society of Nephrology Terms and Conditions

Kidney International 2011 79, 1341-1352DOI: (10.1038/ki.2010.536) Copyright © 2011 International Society of Nephrology Terms and Conditions

Kidney International 2011 79, 1341-1352DOI: (10.1038/ki.2010.536) Copyright © 2011 International Society of Nephrology Terms and Conditions

Kidney International 2011 79, 1341-1352DOI: (10.1038/ki.2010.536) Copyright © 2011 International Society of Nephrology Terms and Conditions

Kidney International 2011 79, 1341-1352DOI: (10.1038/ki.2010.536) Copyright © 2011 International Society of Nephrology Terms and Conditions